7 research outputs found
Analysis Algorithm of Biomedical Signals in Remote Monitoring Systems of Human Health
No full textThe article considers the problems of adaptation of existing and development of new diagnostic algorithms and methods of remote monitoring of the physiological state of a person in relation to the Internet of Things technology. In order to reduce the energy consumption of the wearable unit and biomedical signal sensors, reduce the redundancy of the recorded and transmitted diagnostic information, the critical situation recognition process is divided into two stages. At the first stage, the main indicators (heart rate and human fall signal) are monitored. If they do not comply with the norm, additional signals are analyzed (the second stage) to confirm the critical situa tion and determine the degree of alarm
Алгоритм анализа биомедицинских сигналов в системах дистанционного мониторинга состояния здоровья человека
No full textThe article considers the problems of adaptation of existing and development of new diagnostic algorithms and methods of remote monitoring of the physiological state of a person in relation to the Internet of Things technology. In order to reduce the energy consumption of the wearable unit and biomedical signal sensors, reduce the redundancy of the recorded and transmitted diagnostic information, the critical situation recognition process is divided into two stages. At the first stage, the main indicators (heart rate and human fall signal) are monitored. If they do not comply with the norm, additional signals are analyzed (the second stage) to confirm the critical situa tion and determine the degree of alarm.Рассмотрены задачи адаптации существующих и разработки новых диагностических алгоритмов и методик дистанционного мониторинга физиологического состояния человека применительно к технологии интернета вещей. Для снижения энергопотребления носимого блока и датчиков биомедицинских сигналов, сокращения избыточности регистрируемой и передаваемой диагностической информации процесс распознавания критической ситуации разделен на два этапа. На первом контролируются основные показатели (частота сердечных сокращений и сигнал, информирующий о падении человека). В случае их несоответствия норме выполняется анализ дополнительных сигналов (второй этап) для подтверждения критической ситуации и определения степени тревоги
Modeling and Experimental Approbation of a Hardware and Software Complex for Determining the Impedance Parameters of an Amniotic Fluid
No full textSimulation of the operation of a hardware-software complex for studying the impedance-metric charact eristics of a biological fluid is presented. The impedance-metric parameter was calculated on a previously simulated measuring cell with the objects under study in the COMSOL Multiphysics program. The microcuvette is designed according to the standard of the Litoplast-Med Type A 2.5 ml cuvette, which is subsequently used to test the mo deling results. The results of the study can be used to further prevent threats to the normal course of pregnancy and birth outcomes. The obtained modeling parameters were used for comparison with the results of experimental testing
CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM
No full textstable angina is a socially significant disease that requires significant financial costs to the health system and patients. In recent years the increased heart rate has been considered as a significant risk factor for poor prognosis in stable angina. The aim of the research: assessment of the economic viability of the inclusion of ivabradine in the scheme of treatment of stable angina in terms of health care system of the Republic of Belarus. Material and methods. Markov’s model of ivabradine use in patients with stable angina pectoris has been constructed on the basis of a systematic review of the literature, national surveillance data, local health services market and cardiovascular drugs market estimation. “Cost-effectiveness” and “cost-utility” analyses have been used. The target population of patients suffering from angina pectoris and in need of ivabradine prescription has been estimated with data from clinical studies and national epidemiological data. The potential effectiveness of ivabradine in the Belarusian patient population has been evaluated. Results. The size of the target patient population with stable angina for the ivabradine prescription was 17559 people. The use of ivabradine within 18 months in the target population patient with increased heart rate would allow potentially prevent 366 cases of nonfatal myocardial infarction and unstable angina, 143 cases of cardiovascular death, 391 case of revascularization. According to the results of the analysis the prescription of ivabradine in optimum dose with a minimum cost per 1 mg is the optimum pharmacoeconomic acceptability in patients with stable angina and high heart rate (70 beats per minute)
Cold Atmospheric Plasma Treatment of Medical Devices
No full textPaper summarizes results of cold c plasma use in medical devices surface treatment, focusing at manufacture applications. Attention is given to results of changes in the hydrophilic properties of glass surfaces, stainless steel, polyamide and latex when exposed to atmospheric plasma, depending on the time of treatment with cold plasma and distance to the surface
Смарт-система персонального мониторинга состояния здоровья человека
No full textРассмотрены принципы проектирования системы внегоспитального, вневрачебного мониторинга состояния человека. Изложены медицинские методики классификации физиологического состояния человека, определены соответствующие типы сенсоров биомедицинских сигналов, методов обработки и передачи анализируемой информации и принятия решения
Экономическая и клиническая оценка применения ивабрадина при стабильной стенокардии в системе здравоохранения Республики Беларусь
No full textstable angina is a socially significant disease that requires significant financial costs to the health system and patients. In recent years the increased heart rate has been considered as a significant risk factor for poor prognosis in stable angina. The aim of the research: assessment of the economic viability of the inclusion of ivabradine in the scheme of treatment of stable angina in terms of health care system of the Republic of Belarus. Material and methods. Markov’s model of ivabradine use in patients with stable angina pectoris has been constructed on the basis of a systematic review of the literature, national surveillance data, local health services market and cardiovascular drugs market estimation. “Cost-effectiveness” and “cost-utility” analyses have been used. The target population of patients suffering from angina pectoris and in need of ivabradine prescription has been estimated with data from clinical studies and national epidemiological data. The potential effectiveness of ivabradine in the Belarusian patient population has been evaluated. Results. The size of the target patient population with stable angina for the ivabradine prescription was 17559 people. The use of ivabradine within 18 months in the target population patient with increased heart rate would allow potentially prevent 366 cases of nonfatal myocardial infarction and unstable angina, 143 cases of cardiovascular death, 391 case of revascularization. According to the results of the analysis the prescription of ivabradine in optimum dose with a minimum cost per 1 mg is the optimum pharmacoeconomic acceptability in patients with stable angina and high heart rate (70 beats per minute)
